Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

profileGary Edward Borodic, M.D.

TitleAssistant Professor of Ophthalmology, Part-time
InstitutionMassachusetts Eye and Ear Infirmary
DepartmentOphthalmology
AddressBeyer Townsend and Borodic
100 Charles River Plaza
Boston MA 02114
Phone617/720-0127
vCardDownload vCard (login for email)

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Borodic GE, Hinkle D. Ipilimumab-induced orbital inflammation resembling Graves disease with subsequent development of systemic hyperthyroidism from CTLA-4 receptor suppression. Ophthal Plast Reconstr Surg. 2014 Jan-Feb; 30(1):83. PMID: 24398505.
    View in: PubMed
  2. Borodic GE, Caruso P, Acquadro M, Chick S. Parry-Romberg syndrome vasculopathy and its treatment with botulinum toxin. Ophthal Plast Reconstr Surg. 2014 Jan-Feb; 30(1):e22-5. PMID: 23719195.
    View in: PubMed
  3. Borodic GE. Use of fillers as adjunct therapy for the treatment of lower face hemifacial spasm. Ophthal Plast Reconstr Surg. 2013 May-Jun; 29(3):225-6. PMID: 23559346.
    View in: PubMed
  4. Borodic GE, Hinkle DM. Reply Re: "Drug-induced Graves disease from CTLA-4 receptor suppression". Ophthal Plast Reconstr Surg. 2013 May-Jun; 29(3):241. PMID: 23652295.
    View in: PubMed
  5. Kirzhner M, Jakobiec FA, Borodic G. Desmoplastic trichoepithelioma: report of a unique periocular case. Ophthal Plast Reconstr Surg. 2012 Sep-Oct; 28(5):e121-3. PMID: 22366669.
    View in: PubMed
  6. Borodic G, Hinkle DM, Cia Y. Drug-induced graves disease from CTLA-4 receptor suppression. Ophthal Plast Reconstr Surg. 2011 Jul-Aug; 27(4):e87-8. PMID: 21242854.
    View in: PubMed
  7. Borodic GE. Functional significance of fat surrounding the orbicularis oculi muscle. Ophthal Plast Reconstr Surg. 2010 Nov-Dec; 26(6):501-2. PMID: 20724859.
    View in: PubMed
  8. Borodic GE. Orbicularis oculi myo-osseous fixation: a new treatment for benign essential blepharospasm and blepharospasm associated with diffuse facial dystonia (meige syndrome). Ophthalmic Surg Lasers Imaging. 2010 May-Jun; 41(3):360-9. PMID: 20507022.
    View in: PubMed
  9. Pellett S, Tepp WH, Clancy CM, Borodic GE, Johnson EA. A neuronal cell-based botulinum neurotoxin assay for highly sensitive and specific detection of neutralizing serum antibodies. FEBS Lett. 2007 Oct 16; 581(25):4803-8. PMID: 17889852; PMCID: PMC2748649.
  10. Borodic G. Botulinum toxin, immunologic considerations with long-term repeated use, with emphasis on cosmetic applications. Facial Plast Surg Clin North Am. 2007 Feb; 15(1):11-6, v. PMID: 17317551.
    View in: PubMed
  11. Borodic G. Immunologic resistance after repeated botulinum toxin type a injections for facial rhytides. Ophthal Plast Reconstr Surg. 2006 May-Jun; 22(3):239-40. PMID: 16714951.
    View in: PubMed
  12. Acquadro MA, Borodic GE. Botulinum toxin efficacy for the treatment of pain. J Clin Anesth. 2005 Aug; 17(5):328-30. PMID: 16102679.
    View in: PubMed
  13. Borodic G, Bartley M, Slattery W, Glasscock M, Johnson E, Malazio C, Goodnough M, Acquadro M, McKenna M. Botulinum toxin for aberrant facial nerve regeneration: double-blind, placebo-controlled trial using subjective endpoints. Plast Reconstr Surg. 2005 Jul; 116(1):36-43. PMID: 15988245.
    View in: PubMed
  14. Borodic GE, Acquadro MA. The use of botulinum toxin for the treatment of chronic facial pain. J Pain. 2002 Feb; 3(1):21-7. PMID: 14622850.
    View in: PubMed
  15. Borodic GE, Acquadro M, Johnson EA. Botulinum toxin therapy for pain and inflammatory disorders: mechanisms and therapeutic effects. Expert Opin Investig Drugs. 2001 Aug; 10(8):1531-44. PMID: 11772268.
    View in: PubMed
  16. Tarsy D, Bhattacharyya N, Borodic G. Myasthenia gravis after botulinum toxin A for Meige syndrome. Mov Disord. 2000 Jul; 15(4):736-8. PMID: 10928589.
    View in: PubMed
  17. Troll G, Borodic G. Diplopia after cataract surgery using 4% lidocaine in the absence of Wydase (sodium hyaluronidase) J Clin Anesth. 1999 Nov; 11(7):615-6. PMID: 10624651.
    View in: PubMed
  18. Hayashi N, Borodic G, Karesh JW, Tolentino MJ, Remulla HD, Van Wesep RA, Grossniklaus HE, Jakobiec FA, Green WR. Giant cell angiofibroma of the orbit and eyelid. Ophthalmology. 1999 Jun; 106(6):1223-9. PMID: 10366097.
    View in: PubMed
  19. Borodic G. Myasthenic crisis after botulinum toxin. Lancet. 1998 Dec 05; 352(9143):1832. PMID: 9851395.
    View in: PubMed
  20. Pardo FS, Borodic G. Long-term follow-up of patients undergoing definitive radiation therapy for sebaceous carcinoma of the ocular adnexae. Int J Radiat Oncol Biol Phys. 1996 Mar 15; 34(5):1189-90. PMID: 8600110.
    View in: PubMed
  21. Borodic G, Johnson E, Goodnough M, Schantz E. Botulinum toxin therapy, immunologic resistance, and problems with available materials. Neurology. 1996 Jan; 46(1):26-9. PMID: 8559392.
    View in: PubMed
  22. Pearce LB, First ER, Borodic GE. Botulinum toxin: death versus localized denervation. J R Soc Med. 1995 Apr; 88(4):239-40. PMID: 7745582; PMCID: PMC1295183.
  23. Pearce LB, Borodic GE, Johnson EA, First ER, MacCallum R. The median paralysis unit: a more pharmacologically relevant unit of biologic activity for botulinum toxin. Toxicon. 1995 Feb; 33(2):217-27. PMID: 7597725.
    View in: PubMed
  24. Borodic GE, Duane D, Pearce B, Johnson E. Antibodies to botulinum toxin. Neurology. 1995 Jan; 45(1):204. PMID: 7880304.
    View in: PubMed
  25. Borodic G. Therapeutic botulinum toxin. Lancet. 1994 Nov 12; 344(8933):1370. PMID: 7968058.
    View in: PubMed
  26. Pearce LB, Borodic GE, First ER, MacCallum RD. Measurement of botulinum toxin activity: evaluation of the lethality assay. Toxicol Appl Pharmacol. 1994 Sep; 128(1):69-77. PMID: 8079356.
    View in: PubMed
  27. Borodic GE, Pearce LB. New concepts in botulinum toxin therapy. Drug Saf. 1994 Sep; 11(3):145-52. PMID: 7811397.
    View in: PubMed
  28. Pearce LB, First ER, Borodic GE. Botulinum toxin potency: a mystery resolved by the median paralysis. J R Soc Med. 1994 Sep; 87(9):571-2. PMID: 7932477; PMCID: PMC1294792.
  29. Borodic G, Pearce LB, Johnson E. Antibodies to botulinum toxin. Ophthalmology. 1994 Jul; 101(7):1158-9. PMID: 8035973.
    View in: PubMed
  30. First ER, Pearce LB, Borodic GE. Dose standardisation of botulinum toxin. Lancet. 1994 Apr 23; 343(8904):1035. PMID: 7909062.
    View in: PubMed
  31. Acquadro MA, Borodic GE. Treatment of myofascial pain with botulinum A toxin. Anesthesiology. 1994 Mar; 80(3):705-6. PMID: 8141474.
    View in: PubMed
  32. Borodic GE, Ferrante R, Pearce LB, Smith K. Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections. Mov Disord. 1994 Jan; 9(1):31-9. PMID: 8139603.
    View in: PubMed
  33. Borodic GE, Pearce LB, Cheney M, Metson R, Brownstone D, Townsend D, McKenna M. Botulinum A toxin for treatment of aberrant facial nerve regeneration. Plast Reconstr Surg. 1993 May; 91(6):1042-5. PMID: 8479969.
    View in: PubMed
  34. Borodic GE, Pearce LB, Smith KL, Phelan M, Ferrante R. Botulinum B toxin as an alternative to botulinum A toxin: a histologic study. Ophthal Plast Reconstr Surg. 1993; 9(3):182-90. PMID: 8217959.
    View in: PubMed
  35. Borodic GE, Cheney M, McKenna M. Contralateral injections of botulinum A toxin for the treatment of hemifacial spasm to achieve increased facial symmetry. Plast Reconstr Surg. 1992 Dec; 90(6):972-7; discussion 978-9. PMID: 1448532.
    View in: PubMed
  36. Borodic GE, Ferrante R. Effects of repeated botulinum toxin injections on orbicularis oculi muscle. J Clin Neuroophthalmol. 1992 Jun; 12(2):121-7. PMID: 1385821.
    View in: PubMed
  37. Borodic GE, Pearce LB, Smith K, Joseph M. Botulinum a toxin for spasmodic torticollis: multiple vs single injection points per muscle. Head Neck. 1992 Jan-Feb; 14(1):33-7. PMID: 1624292.
    View in: PubMed
  38. Borodic GE, Ferrante R, Wiegner AW, Young RR. Treatment of spasticity with botulinum toxin. Ann Neurol. 1992 Jan; 31(1):113. PMID: 1543342.
    View in: PubMed
  39. Borodic GE. Botulinum A toxin for (expressionistic) ptosis overcorrection after frontalis sling. Ophthal Plast Reconstr Surg. 1992; 8(2):137-42. PMID: 1520657.
    View in: PubMed
  40. Borodic GE, Mills L, Joseph M. Botulinum A toxin for the treatment of adult-onset spasmodic torticollis. Plast Reconstr Surg. 1991 Feb; 87(2):285-9. PMID: 1989021.
    View in: PubMed
  41. Borodic GE, Cozzolino D, Ferrante R, Wiegner AW, Young RR. Innervation zone of orbicularis oculi muscle and implications for botulinum A toxin therapy. Ophthal Plast Reconstr Surg. 1991; 7(1):54-60. PMID: 1708272.
    View in: PubMed
  42. Borodic GE, Joseph M, Fay L, Cozzolino D, Ferrante RJ. Botulinum A toxin for the treatment of spasmodic torticollis: dysphagia and regional toxin spread. Head Neck. 1990 Sep-Oct; 12(5):392-9. PMID: 2211099.
    View in: PubMed
  43. Borodic GE, Cozzolino D. Blepharospasm and its treatment, with emphasis on the use of botulinum toxin. Plast Reconstr Surg. 1989 Mar; 83(3):546-54. PMID: 2645599.
    View in: PubMed
  44. Borodic GE, Townsend DJ, Beyer-Machule CK. Dermis fat graft in eviscerated sockets. Ophthal Plast Reconstr Surg. 1989; 5(2):144-9. PMID: 2487209.
    View in: PubMed
  45. Borodic GE, Beyer-Machule CK, Millin J, Conte J, Foster CS. Immunoglobulin deposition in localized conjunctival amyloidosis. Am J Ophthalmol. 1984 Nov; 98(5):617-22. PMID: 6496617.
    View in: PubMed
  46. Borodic GE, Gragoudas ES, Edward WO, Brockhurst RJ. Peripapillary subretinal neovascularization and serous macular detachment. Association with congenital optic nerve pits. Arch Ophthalmol. 1984 Feb; 102(2):229-31. PMID: 6199007.
    View in: PubMed
  47. Calderone JP, Chess J, Borodic G, Albert DM. Intraocular pathology of trisomy 18 (Edwards's syndrome): report of a case and review of the literature. Br J Ophthalmol. 1983 Mar; 67(3):162-9. PMID: 6824623; PMCID: PMC1040001.
  48. Ashikaga T, Borodic G, Sims EA. Multiple daily insulin injections in the treatment of diabetic retinopathy. The Job study revisited. Diabetes. 1978 May; 27(5):592-6. PMID: 648750.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Borodic's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_